Cargando…

Fibrinolytic changes in pregnant women on highly active antiretroviral therapy

OBJECTIVES: To report on the changes in fibrinolytic activity in human immunodeficiency virus (HIV) infected pregnant women who are undergoing highly active antiretroviral therapy (HAART). METHODS: Blood was collected from 50 HIV positive women on HAART (test subjects), and 50 HIV positive women not...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osime, Odaburhine E., Ese-Onakewhor, Joseph U., Kolade, Samson O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Saudi Medical Journal 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375698/ https://www.ncbi.nlm.nih.gov/pubmed/25719585 http://dx.doi.org/10.15537/smj.2015.2.10372

Ejemplares similares

Effect of highly active antiretroviral therapy (HAART) on some specific clotting profile in Human Immunodeficiency Virus -(HIV) positive pregnant women
por: Evarista, Osime Odaburhine, et al.
Publicado: (2020)

Packed cell volume Platelet count, PT, PTTK and Fibrinogen concentration of HIV positive patients on antiretroviral drugs
por: Osime, Evarista Odaburhine, et al.
Publicado: (2015)

Fibrinolytic Changes in Women with Preeclampsia
por: Godtfredsen, Anne Cathrine, et al.
Publicado: (2022)

Determinants and outcome of fetal macrosomia in a Nigerian tertiary hospital
por: Olokor, Oghenefegor Edwin, et al.
Publicado: (2015)

A case of hemothorax secondary to intrapleural fibrinolytic therapy: Considerations for use of fibrinolytics in high-risk patients
por: Narula, Naureen, et al.
Publicado: (2021)

Comparison of Two Antiretroviral Therapy Regimens in Human Immunodeficiency Virus (HIV−) Infected Pregnant Women
por: Tate, Danielle, et al.
Publicado: (2017)

Fibrinolytic Therapy in Acute Stroke
por: Millán, Mònica, et al.
Publicado: (2010)

Perspective on fibrinolytic therapy in COVID-19: the potential of inhalation therapy against suppressed-fibrinolytic-type DIC
por: Asakura, Hidesaku, et al.
Publicado: (2020)

THE FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI
por: Tillett, William S., et al.
Publicado: (1933)

Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
por: Ngemu, Erastus K, et al.
Publicado: (2014)

The Cost-Effectiveness of Directly Observed Highly-Active Antiretroviral Therapy in the Third Trimester in HIV-Infected Pregnant Women
por: McCabe, Caitlin J., et al.
Publicado: (2010)

Immunity and coagulation and fibrinolytic processes may reduce the risk of severe illness in pregnant women with coronavirus disease 2019
por: Zhong, Yajuan, et al.
Publicado: (2021)

Plasma levels of fibrinolytic and coagulation biomarkers in HIV‐infected individuals on highly active antiretroviral therapy: A case‐control study in a Northern Ghanaian population
por: Derigubah, Charles A., et al.
Publicado: (2023)

Married men’s perceptions of barriers for HIV-positive pregnant women accessing highly active antiretroviral therapy in rural Uganda
por: Duff, Putu, et al.
Publicado: (2012)

Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity
por: Kuiper, Gerhardus J. A. J. M., et al.
Publicado: (2016)

Fibrinolytic and coagulative activities of Yersinia pestis
por: Korhonen, Timo K., et al.
Publicado: (2013)

Haematological and fibrinolytic status of Nigerian women with post-partum haemorrhage
por: Roberts, Ian, et al.
Publicado: (2018)

Fibrinolytic therapy for parapneumonic empyema during pregnancy
por: Ulutas, Hakki, et al.
Publicado: (2011)

VATS and Intrapleural Fibrinolytic Therapy for Parapneumonic Empyema
por: Ohara, Gen, et al.
Publicado: (2018)

Role of Fibrinolytic Enzymes in Anti-Thrombosis Therapy
por: Altaf, Farwa, et al.
Publicado: (2021)

Efficacy of standardizing fibrinolytic therapy for parapneumonic effusion
por: James, Charles A., et al.
Publicado: (2022)

Retraction Note: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
por: Ngemu, Erastus K, et al.
Publicado: (2014)

Antiretroviral therapy in pregnant women living with HIV: a clinical practice guideline
por: Siemieniuk, Reed A C, et al.
Publicado: (2017)

Outcome expectancies toward adherence to antiretroviral therapy for pregnant and postpartum women with HIV
por: Momplaisir, Florence M, et al.
Publicado: (2021)

Changes in the Coagulation and Fibrinolytic System of Patients with Subarachnoid Hemorrhage
por: JI, Yong, et al.
Publicado: (2014)

Reduction of Maternal Mortality with Highly Active Antiretroviral Therapy in a Large Cohort of HIV-Infected Pregnant Women in Malawi and Mozambique
por: Liotta, Giuseppe, et al.
Publicado: (2013)

Changes in Coagulation and Fibrinolytic Indices in Women with Polycystic Ovarian Syndrome Undergoing Controlled Ovarian Hyperstimulation
por: Huang, Ying, et al.
Publicado: (2014)

Ambulatory Intrapleural Fibrinolytic Therapy in Highly Viscous Recurrent Malignant Pleural Effusion
por: Foo, Chuan Tai, et al.
Publicado: (2021)

Antiplatelet, Antithrombotic, and Fibrinolytic Activities of Campomanesia xanthocarpa
por: Klafke, Jonatas Zeni, et al.
Publicado: (2012)

Correction: Reduction of Maternal Mortality with Highly Active Antiretroviral Therapy in a Large Cohort of HIV-Infected Pregnant Women in Malawi and Mozambique
por: Liotta, Giuseppe, et al.
Publicado: (2013)

Pattern and Determinants of Antiretroviral Drug Adherence among Nigerian Pregnant Women
por: Ekama, S. O., et al.
Publicado: (2012)

Impact of short-term antiretroviral therapy (START) on some fibrinolytic markers in HIV-infected Nigerian adults: preliminary findings from the START study
por: Jeremiah, Zaccheaus A, et al.
Publicado: (2012)

Therapeutics targeting the fibrinolytic system
por: Lin, Haili, et al.
Publicado: (2020)

The Fibrinolytic System: Mysteries and Opportunities
por: Medcalf, Robert L., et al.
Publicado: (2021)

Evidence of Subclinical mtDNA Alterations in HIV-Infected Pregnant Women Receiving Combination Antiretroviral Therapy Compared to HIV-Negative Pregnant Women
por: Money, Deborah M., et al.
Publicado: (2015)

Adherence to HIV Antiretroviral Therapy Among Pregnant and Breastfeeding Women, Non-Pregnant Women, and Men in Burkina Faso: Nationwide Analysis 2019–2020
por: Zoungrana-Yameogo, Wedminere Noëlie, et al.
Publicado: (2022)

Precision targeting of the plasminogen activator inhibitor‐1 mechanism increases efficacy of fibrinolytic therapy in empyema
por: Florova, Galina, et al.
Publicado: (2021)

Potential fibrinolytic activity of an endophytic Lasiodiplodia pseudotheobromae species
por: Meshram, Vineet, et al.
Publicado: (2016)

Assessing plasminogen activation potential with global fibrinolytic assays
por: Urano, Tetsumei, et al.
Publicado: (2019)

Evaluation of fibrinolytic medical therapy for patients with acute myocardial infarction
por: Maleki, Ali, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jprm65p32t9ssa37hks3nc4rml